Nom du produit:Ethyl 2-(3-cyclopropyl-6-oxopyridazin-1(6H)-yl)acetate
IUPAC Name:ethyl 2-(3-cyclopropyl-6-oxo-1,6-dihydropyridazin-1-yl)acetate
- CAS：2098136-65-1
- Formule moléculaire：C11H14N2O3
- Pureté：97%
- Numéro de catalogue：CM557913
- Poids moléculaire：222.24
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2098136-65-1
- Formule moléculaire:C11H14N2O3
- Point de fusion:-
- Code SMILES:O=C(C=C1)N(CC(OCC)=O)N=C1C2CC2
- Densité:
- Numéro de catalogue:CM557913
- Poids moléculaire:222.24
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Pyridazines
- Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.
- Cyclopropanes
- Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.
Recherche 
+86 21 5895 0110 
